We instead found a translocation of S100A4 expression from cytoplasmic to nuclear in five samples with advanced disease stage, suggesting that S100A4 translocation to the nucleus may be related to the proliferation or metastatic potential of the cancer cells. Here, S100A4 is linked to cancer.